ReviewThe Journal of surgical research2014
Immunotherapy for solid tumors--a review for surgeons.
Review in The Journal of surgical research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Implications of IL-21 in solid tumor therapy.Medical oncology (Northwood, London, England) · 2023Review
- Challenges in assessing solid tumor responses to immunotherapy.Cancer gene therapy · 2020Review
- Hydrothermal synthesis, characterization and enhanced photocatalytic activity and toxicity studies of a rhombohedral FeRSC advances · 2019Article
- Soft tissue sarcomas in the precision medicine era: new advances in clinical practice and future perspectives.La Radiologia medica · 2019Review
- Intraperitoneal immunotherapy: historical perspectives and modern therapy.Cancer gene therapy · 2016Review
- Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery.Cancer gene therapy · 2016Article
- Article
- Neutrophil:lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor-modified T-cell infusions for liver metastases.Cancer gene therapy · 2014Article
- The prognostic value of liver tumor T cell infiltrates.The Journal of surgical research · 2014Review
- Cancer immunotherapy in clinical practice -- the past, present, and future.Chinese journal of cancer · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Immunotherapy has evolved considerably in the last decade and is becoming an integral component of the armamentarium for the treatment of patients with advanced solid tumors. It is important for clinicians, especially surgeons, to understand the basic principles of novel immunotherapies and the immune system. This review summarizes the evolution of the most relevant immunotherapies, their mechanisms of action, the data supporting their clinical use, and integration of immunotherapy into multidisciplinary management of solid tumors. This review should serve as a primer for clinicians and surgeons to understand the rapidly evolving field of immunotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.